Literature DB >> 25651718

Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.

Peicheng Shen, Jiaojiao Shen, Wenwen Li, Liqun He.   

Abstract

BACKGROUND: To evaluate the clinical significance of the urinary podocytes in patients with IgA nephropathy.
METHODS: Urine samples from 102 biopsy-confirmed IgA nephropathy patients were collected to detect urinary podocytes using an indirect immunofluorescence staining method with anti-human Podocalyxin (PCX) antibody. Then, correlation analysis was performed between the urinary podocyte counts and the clinicopathological changes.
RESULTS: Upon comparison with IgA nephropathy patients with negative urinary podocytes, IgA nephropathy patients with positive urinary podocytes presented a significant reduction in plasma albumin and glomerular filtration rate and remarkable rise in urinary protein excretion, blood cholesterol, and mean arterial pressure. Pathologically, the renal tissues of IgA nephropathy patients with positive urinary podocytes presented less podocytes in the glomerulus (6.03 ± 3.61 cells/glomerulus vs. 12.58 ± 7.23 cells/glomerulus, p < 0.001), more mesangial matrix, and more aggravated interstitial fibrosis and foot process fusion than in IgA nephropathy patients with negative urinary podocytes. In addition, the urinary podocyte counts were positively correlated with serum creatinine and 24-hour urinary protein excretion (r = 0.332, p < 0.05 and r = 0.387, p < 0.05, respectively) and negatively correlated with the number of podocytes in the renal tissues (r = -0.416, p 0 < 0.05).
CONCLUSIONS: Detection of urinary podocytes can be a noninvasive indicator for reflecting the severity of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25651718     DOI: 10.7754/clin.lab.2014.131225

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  7 in total

1.  How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?

Authors:  Shikai Liang; Juan Jin; Jianguang Gong; Bo Lin; Yiwen Li; Qiang He
Journal:  Int Urol Nephrol       Date:  2016-08-31       Impact factor: 2.370

2.  [Value of podocalyxin levels in urinary extracellular vesicles for diagnosis of diabetic nephropathy].

Authors:  Fan Wu; Yunyin Chen; Hua Xiao; Ziliang Zou; Jing Ning; Haishan Chen; Hequn Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-08-30

3.  Urinary levels of podocyte-derived microparticles are associated with the progression of chronic kidney disease.

Authors:  Jian Lu; Ze-Bo Hu; Pei-Pei Chen; Chen-Chen Lu; Jia-Xiu Zhang; Xue-Qi Li; Ben-Yin Yuan; Si-Jia Huang; Kun-Ling Ma
Journal:  Ann Transl Med       Date:  2019-09

Review 4.  Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.

Authors:  Lesley A Inker; Hiddo J L Heerspink; Hocine Tighiouart; Juhi Chaudhari; Shiyuan Miao; Ulysses Diva; Alex Mercer; Gerald B Appel; James V Donadio; Jürgen Floege; Philip K T Li; Bart D Maes; Francesco Locatelli; Manuel Praga; Francesco P Schena; Andrew S Levey; Tom Greene
Journal:  Am J Kidney Dis       Date:  2021-03-26       Impact factor: 11.072

5.  Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.

Authors:  Brent Fall; C Ronald Scott; Michael Mauer; Stuart Shankland; Jeffrey Pippin; Jonathan A Jefferson; Eric Wallace; David Warnock; Behzad Najafian
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

Review 6.  Exfoliated Kidney Cells from Urine for Early Diagnosis and Prognostication of CKD: The Way of the Future?

Authors:  Henry H L Wu; Ewa M Goldys; Carol A Pollock; Sonia Saad
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

7.  Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy.

Authors:  Shikai Liang; Juan Jin; Xiaogang Shen; Xinxin Jiang; Yiwen Li; Qiang He
Journal:  Exp Ther Med       Date:  2018-07-19       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.